Aug. 5, 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs

Dec. 18, 2007
Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detectsm, Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007

Dec. 11, 2007
Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits

Dec. 5, 2007
Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product

Nov. 14, 2007
Panacea Pharmaceuticals Announces the Availability of CC Detectsm, a Serum-Based Diagnostic Test for Colon Cancer

Panacea's mission is to discover, develop and commercialize innovative therapeutic and diagnostic products. Our current product development focus is on novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, as well as neurodegenerative diseases such as stroke, Alzheimer's Disease, and Parkinson's Disease.